Document:

Exhibit 10.6
                                  ------------
                                   Visx (logo)

                                 PATENT LICENSE
                                 --------------

This Patent License (this "License") is entered into by and between VISX,
Incorporated ("VISX") and the Licensee listed below in connection with the use
of the VISX STAR S2(TM) Excimer Laser System Serial Number C3095 _ (the
"System") and is effective as of the date of the later of the parties signatures
set out below.
------------------------------------------------|-------------------------------
The Licensee is:                                | The Authorized Users are:
Lasik America, Inc.                             | Stuart Cooper, M.D.
6644 Indian School Rd. NE                       | Alfred Lovato Jr., M.D.
Albuquerque, NM 87110                           | Donald E. Rodgers, M.D.
                                                | Stephen Graham, M.D.
System shall initially be installed at ("Site") | The License Fee is $100.00 per
                                                | Licensed Procedure
------------------------------------------------|-------------------------------
A.       WHO MAY USE THE SYSTEM?
         -----------------------

Authorized Users. Licensee and the individuals designated above (the "Authorized
------------------
Users") are the only persons permitted to use the System. Licensee shall permit
only eye care practitioners who have experience in the surgical management and
treatment of the cornea and who are legally qualified, properly licensed and
fully trained and certified by VISX (or its designees) to perform Licensed
Procedures (as defined below) on the System. Licensee will provide VISX at least
10 days prior written notice of any change in the designated Authorized Users.
Licensee represents, warrants and covenants that it is and its Authorized Users
are, and will remain for so long as Licensee is using the System, fully licensed
and legally qualified and certified by VISX to perform the specific Licensed
Procedure to be performed, and that Licensee and its Authorized Users shall
remain trained in the proper techniques for performing that Licensed Procedure
in the most effective and safe manner. Licensee shall notify VISX promptly of
any exception to the foregoing representation, warranty and covenant.

B.       INTELLECTUAL PROPERTY RIGHTS
         ----------------------------

1.   Patents.   The  System,   the  VisionKey  (R)  card,  and  certain  related
     -------
     disposables, and their use, are covered by several United States patents
     for which VISX has the authority to provide this License. A list of these
     patents is set forth in Schedule A (the "Patents"). The Patents cover

                                        1

<PAGE>
     apparatus and methods for performing ophthalmic laser surgery. Use of the
     System to perform any procedure covered by the Patents is prohibited unless
     such use is authorized by a valid VISX Patent License. The sale, lease or
     other transfer of the System by VISX or any other person or entity does not
     in any way grant a license under any Patent to use the System to perform
     any procedures. Such license may only be granted by the delivery to VISX of
     a fully-executed VISX Patent License.

2.   Ownership of Intellectual  Property Rights. VISX owns all right, title, and
     ------------------------------------------
     interest in the VisionKey cards, and in all of VISX's patents, trademarks,
     trade names, inventions, copyrights, know-how, and trade secrets relating
     to the design, use, manufacture, operation or service of the System and
     relating to performance of Licensed Procedures. The use by Licensee of any
     of these intellectual property rights is permitted only for the purposes
     authorized in this License and only in connection with use of the System,
     and upon termination of this License for any reason such authorization
     shall cease. Licensee recognizes that performance of the Licensed
     Procedures without payment of the License Fee constitutes infringement of
     VISX's intellectual property rights.

C.       GRANT
         -----

1.   License  Grant.  Subject to  Licensee's  compliance  with the terms of this
     --------------
     License. VISX continuations, continuations-in-part, divisional patents,
     reexaminations, renewals, hereby grants to Licensee the right and license
     under the Patents (including any extensions and reissues of such Patents)
     to perform, and permit Authorized Users to perform, any ultraviolet laser
     corneal surgery procedure using the System and related disposables, which
     performance or use is covered by at least one claim of a Patent (a
     "Licensed Procedure") at the Site. Upon breach by Licensee of any of its
     obligations contained in this License, the license granted hereby shall be
     revoked and VISX shall have the right, without notice or demand, to disable
     or take possession of the System. This License is limited to the
     performance of Licensed Procedures using the System.

2.   Consideration.  In consideration  for the license granted under the Patents
     -------------
     pursuant to Section C.1, Licensee shall pay the License Fee listed on the
     front page of this License each time the System is used to perform a
     Licensed Procedure, except that the License Fee shall be $-0- each time the
     System is used to perform a phototherapeutic keratectomy (PTK). For
     convenience of the parties, payment of the License Fee is due upon shipment
     of each VisionKey card and payable on the terms set forth in the Sales or
     Lease Agreement. The License Fee does not include the cost of the card.

3.   Tampering.  Licensee is  prohibited  from  tampering  with or attempting to
     ---------
     reverse engineer the VisionKey card or any device or software installed on
     the System for the purpose of monitoring the number of Licensed Procedures
     performed. MODIFYING OR ALTERING THE SYSTEM, THE VISIONKEY CARD OR THE CARD
     READING MECHANISM IN ANY WAY CONSTITUTES WILLFUL INFRINGEMENT OF THE
     INTELLECTUAL PROPERTY LICENSED UNDER THIS LICENSE AND MAY ENDANGER PATIENT

                                        2
<PAGE>
     SAFETY. ANY SUCH MIDIFICATIONOR ALTERATION WILL RENDER THE SYSTEM
     ADULTERATED UNDER THE FEDERAL FOOD, DRUG AND COSMETIC ACT AND COULD SUBJECT
     THE LICENSEE AND/OR THE AUTHORIZED USERS TO ACTION BY THE FDA RESULTING IN
     SEIZURE, INJUNCTION, CIVIL PENALTIES, AND/OR CRIMINAL PROSECUTION.

4.   Term and  Termination.  This License will continue  until the expiration of
     ---------------------
     the last of the Patents to expire and Licensee's obligation to pay the
     License Fee shall terminate for a given procedure on the expiration of the
     last of the Patents containing one or more claims which cover use of the
     System or performance of such procedure. This License may be terminated at
     any time by VISX if (a) Licensee fails to make any payment due under this
     License within 30 days of the due date, (b) Licensee has tampered in any
     way with the VisionKey card or the card reading mechanism, the software
     installed in the System, or any other part of the System, or (c) Licensee
     fails to cure any other breach of this License within 30 days after VISX
     provides written notice of such breach to Licensee. Upon any early
     termination, Licensee and all Authorized Users shall cease all use of the
     System. Licensee understands that the security interest in the system
     granted to VISX in the Sales or Lease secures performance of Licensee's
     obligations under this License. The respective rights and obligations of
     VISX and Licensee under the provisions of Sections C.3, C.4, D.2, E.1, E.2,
     and E.4 shall survive any termination of this License.

D.       LOCATION AND CONDITION OF THE SYSTEM
         ------------------------------------

1.   Initial Installation Site.  The System shall initially be installed  at the
     -------------------------
     Site designated on the first page of this License.

2.   Relocation  and Transfer.  Licensee shall not move the System from the Site
     ------------------------
     unless it provides at least 30 days prior written notice of the new site to
     VISX. Licensee man not sell or otherwise transfer the System unless the
     proposed transferee has entered into the then current form of VISX Patent
     License for the System, at which time this License shall terminate and
     Licensee's rights under this License shall expire. Licensee may not
     transfer or sublicense any of its rights or obligations under this License
     without VISX's prior written consent, except as may be implicit in its
     granting the Authorized Users the privilege to use the System pursuant to
     this License.

3.   Use and Maintenance. Licensee and the Authorized Users shall use the System
     -------------------
     only in accordance with the procedures and other requirements set forth in
     the user's manuals or other documentation accompanying the System or
     otherwise provided to Licensee by VISX. Licensee shall cause the System to
     be properly maintained in accordance with VISX's service recommendations
     and shall ensure that all Licensed Procedures performed using the System
     are performed in a safe and effective manner. Licensee shall not be
     obligated by this License to retain VISX or any of its affiliates to
     perform maintenance on the System.

                                        3
<PAGE>
4.   Access to System.  Licensee shall allow VISX, at VISX's sole expense,  from
     ----------------
     time to time to install or to attach to the System, and to modify, adjust
     and read, a memory, recording or other device and/or software (including
     telephone connections of the devices with VISX) which measures the number
     and types of Licensed Procedures performed with the System. Licensee shall
     not permit anyone other than an authorized VISX representative to alter or
     remove any such devices or software. In addition, Licensee shall permit
     VISX, its affiliates and authorized representatives to inspect the System
     and/or Licensee's records at least once per month during reasonable
     business hours and upon at least 48 hours prior notice for the purpose of
     obtaining the information measured by any device or software installed on
     the System and to monitor Licensee's compliance with the terms of this
     License.

E.       LIABILITY, IMMUNITY, AND COMPLIANCE WITH LAWS
         ---------------------------------------------

1.   Disclaimer  of  Liability.   VISX  SHALL  NOT  BE  LIABLE  FOR  INCIDENTAL,
     -------------------------
     CONSEQUENTIAL, INDIRECT OR SPEICAL DAMAGES OF ANY KIND, INCLUDING BUT NOT
     LIMITED TO DAMAGTES FOR LOSS OF REVENUE, LOSS OF DATA, LOSS OF BUSINESS OR
     BUSINESS OPPORTUNITY OR OTHER FINANCIAL LOSS ARISING OUT OF OR IN
     CONNECITON WITH THE SALE, INSTALLATION, PERFOMANCE, FAILURE, USE OR
     INTERRUPTED USE OF ITS PRODUCTS, OR THE UNAUTHORIZED USE OF THE PRODUCTS.
     VISX'S LIABILITY FOR ANY LOSS OR DAMAGE ARISING OUT OF OR RESULTING FROM
     THIS LICENSE OR ITS PERFORMANCE OR BREACH, OR IN CONNECTION WITH THE
     PRODUCTS FURNISHED PURSUANT TO THIS LICENSE, WILL IN NO CASE EXCEED THE
     PRICE OF THE SPECIFIC PRODUCT WHICH GIVES RISE TO THE CLAIM.

2.   Required  Insurance.  Licensee shall maintain general  liability  insurance
     -------------------
     covering use of the System. Such insurance shall name VISX as an additional
     insured and shall be in minimum amounts of $1,000,000 per occurrence,
     $5,000,000 annual aggregate. Licensee shall obtain from each Authorized
     User proof of professional liability insurance in minimum amounts of
     $1,000,000 per occurrence, $3,000,000 annual aggregate.

3.   Immunity and  Indemnification.  So long as the Licensee and its  Authorized
     -----------------------------
     Users comply in full with this License Agreement. VISX hereby grants
     immunity to the Licensee and the Authorized Users from any infringement or
     other legal action under the Patents arising from Licensee's use of the
     System to perform Licensed Procedures. VISX makes no representation or
     warranty regarding the scope or validity of any of the Patents. VISX agrees
     to indemnify Licensee and its Authorized Users against liability actually
     and reasonably incurred arising from a third party claim that the
     possession or use of the System in accordance with VISX's instructions for
     us constitutes an infringement of any United States patent or other
     intellectual property right of such third party. This indemnification is
     subject to the following conditions: (a) Licensee must notify VISX
     immediately upon receipt of notice of any such claim, (b) Licensee must

                                        4
<PAGE>
     keep VISX fully informed of any developments in connection with any such
     claim, (c) Licensee shall cooperate fully with VISX in the defense of any
     such claim, and (d) VISX shall have the right to undertake the defense,
     compromise or settlement of any such claim on Licensee's behalf, subject to
     Licensee's approval which approval shall not unreasonably be withheld. No
     implied licenses are created by this provision.

4.   Compliance  with Laws.  Licensee  shall comply  with,  and shall cause each
     ---------------------  Authorized User to comply with, all laws, rules and
     regulations of any governmental authority applicable to use of the System,
     including without limitation the federal Food, Drug and Cosmetic Act and
     any labeling requirements of the United States Food and Drug Administration
     Licensee shall permit VISX to affix to the System additional notices that
     VISX reasonably deems necessary. Licensee shall not remove or tamper with
     any notices or labels affixed to the System.

F.       GENERAL PROVISIONS
         ------------------
This License between VISX And Licensee is binding on their respective successors
and permitted assigns and legal representatives. This License is subject to and
interpreted under the laws of the State of California (without regard to
principle of conflict of laws) and cannot be amended, nor can any term be
waived, except in a writing signed by both parties. Any controversy or claim
arising out of or relating to this License, or the breach thereof, shall be
settle by arbitration administered by the American Arbitration Association under
its Commercial Arbitration Rules, and judgment on the award rendered by the
arbitrator(s) may be entered in any court having jurisdiction thereof, provided
however, that neither party shall be precluded from seeking injunctive relief in
a court of law. No waiver or modification in any one instance shall be a waiver
or modification in any other. No third party rights will be created by the
execution or performance of this License. This License together with the Sales
or Lease Agreement, as applicable, contains the entire understanding between
VISX and Licensee with respect to its subject matter and supersedes all other
agreements, discussions, and understandings with respect to the subject matter.
Notices under this License shall be sent by overnight courier to the principal
offices of the subject party. If any provision (or part of any provision) of
this License, or the enforcement thereof, is held to be illegal, invalid, or
unenforceable, then the parties shall renegotiate this License promptly and in
good faith so as to place each of the parties, to the fullest extent legally
possible, in substantially the same economic position as each of them would have
been if such illegality, invalidity, or unenforceability had not occurred.
Section and subsection headings in this License are included for convenience of
reference only and shall not constitute part of this License for any other
purpose or be given any substantive effect. This License may be executed in one
or more counterparts all of which together shall constitute one original
document.

VISX, INCORPORATED                          LICENSEE

Signature:                                  Signature: /s/ Robert Helmer
          ----------------------------                ------------------------
Name:                                       Name: Robert Helmer
      --------------------------------           -----------------------------
Title:                                      Title: Chief Operating Officer
      --------------------------------             ---------------------------
Date:                                       Date:    5/11/01
      --------------------------------           -----------------------------
                                        5
<PAGE>
                                   SCHEDULE A
                                   ----------
                              United States Patents
Patent Name                                                   U.S. Patent No.
-------------                                                   ---------------
VISX Patents
--------------
  Method for Ophthalmological Surgery                              4,665,913
  Method and Apparatus for Analysis and Correction                 4,669,466
  Abnormal Refractive Errors of the Eye
  Apparatus for  Ophthalmological  Surgery                         4,718,418
  Apparatus for Analysis and Correction of Abnormal Refractive     4,721,379
  Errors of the Eye
  Apparatus for Performing Ophthalmic Laser Surgery                4,729,372
  Method for Performing Ophthalmological Surgery                   4,732,148
  Method of Laser-Sculpture of the Optically Used Portion of       4,773,414
  The Cornea
  Method of Laser-Sculpture of the Optically Used Portion of       4,798,204
  The Cornea
  Ultraviolet Radiometer                                           4,885,471
  Topography  Measuring  Apparatus                                 4,902,123
  Method and Apparatus for Performing A Keratomileusis or the      4,903,695
  Like Operation  (includes LASIK)
  Eye Restraining Device                                           4,905,711
  Sculpture Apparatus for Correcting  Curvature of Cornea          4,911,711
  Beam Intensity Profilometer                                      4,916,319
  Topography Measuring Apparatus                                   4,993,826
  Topography Measuring Apparatus                                   4,998,819
  Gas Purging, Eye Fixation Hand Piece                             5,009,660
  Topography Measuring Apparatus                                   5,106,183
  Laser Surgery Method (Includes LASIK)                            5,108,388
  Photorefractive Keratectomy                                      5,163,934
  Method and Apparatus for Ophthalmologic Surgery                  5,188,831
  Method and Apparatus for Ophthalmologic Surgery                  5,207,668
  Apparatus for Performing Ophthalmologic Surgery                  5,219,343
  Method and Apparatus for Laser Sculpture of the Cornea           5,219,344
  Apparatus for Perfoming Ophthalmological Surgery                 5,312,320
  Rectilinear Photokeratoscope                                     5,339,121
  Ophthalmic Method for Laser Surgery of the Cornea                5,507,741
  In Situ Astigmatism Axis Alignment                               5,549,597
  Method and System for Laser Treatment of Refractive Error        5,556,395
  Using an Offset Image of a Rotatable Mask
  Method and Apparatus for Temporal and Spatial Beam Integration   5,646,791
  Laser Surgery Apparatus and Method                               5,711,762
  Laser Surgery Apparatus and Method                               5,735,843
  Method and Apparatus for Temporal and Spatial Beam Integration   5,912,775

IBM Patent
------------
  Far Ultraviolet Surgical and Dental Procedures                   4,784,135

                                        6

<PAGE>
Summit Patents
----------------
  Laser Reprofiling Systems and Methods                            4,856,513
  Surface Erosion Using Lasers                                     4,941,093
  Surgical Apparatus for Modifying the Curvature of the Eye Cornea 4,973,330
  Surface Shaping Using Laser                                      4,994,058
  LaserReprofiling system Employing an Erodable Mask               5,019,074
  Optical System for Use in a Surgical Apparatus                   5,147,352
  Laser Reprofiling System Employing a Photodecomposable Mask      5,432,801
  Laser Corneal Surgery                                            5,423,801

                                        7Exhibit 10.7
                                  ------------

     ---------------------------------------------------
     555 West Arrow Highway                 909-624-2020
     Claremont, CA 91711 USA                909-338-2020
     ---------------------------------------------------
                                                                      BAUSCH
                               BAUSCH AND LOMB, INC.                  & LOMB
                               RENT TO OWN PROGRAM
--------------------------------------------------------------------------------
Customer:         Lasik America, Inc.                   Account Number: 146820
Address:          6644 Indian School Road NE
City, State Zip:  Albuquerque, NM 87110
Customer is a     /s/Corporation (corporation, partnership, sole proprietor)
                  --------------
--------------------------------------------------------------------------------
This Agreement is entered into by BAUSCH AND LOMB, a New York corporation, with
offices at 555 West Arrow Highway, Claremont California, 91711 (hereafter
referred to as "B&L"), and the Customer listed above (hereafter referred to as
"Customer").

Description of Program
Under the program, Customer leases the Equipment for a term of six (6) months or
longer. At the end of the lease, Customer has the option to purchase the B&L
equipment set forth in III.2. A portion of the rental paid by Customer will then
be credited toward Customer's payment of the Purchase Price, subject to the
limits set forth in III.4.

                                  SCHEDULE "A"
                                   EQUIPMENT*
--------------------------------------------------------------------------------
QTY.    PRODUCTS                                                     PRICES
 1      Hansatome (R) Microkeratome Unit                             $40,000.00
        VALUE OF EQUIPMENT INCLUDED HEREIN                           $40,000.00
--------------------------------------------------------------------------------
        507-0028 Accuglide Blades                                   $65.00 each
--------------------------------------------------------------------------------
*All references to Equipment in this Agreement refer to the Equipment as
described in Schedule "A" above.
--------------------------------------------------------------------------------
I.  Duties of Customer

1.  Subject to the terms and conditions of this Agreement, Customer agrees to
lease the Equipment from B&L for a period of six (6) months., commencing upon
                        ----                     ---
installation of the Equipment (the "Term").

2. Customer agrees to pay $1,800 per month to B&L as rental for the Equipment
(the "Rental"), payable at the above address, in arrears, on or before the
fifteenth (15th) day of the month following each month of the Term.

                                        1
<PAGE>
3. Customer agrees to pay any applicable state and local taxes on the leasing or
purchase of the Equipment, and any shipping/return shipping charges. Tax exempt
accounts will not be charged taxes.

4. Customer agrees to return the Equipment, at Customer's expense, at the end of
the Term in good condition and repair, ordinary wear and tear excepted.

5. Customer authorizes and appoints B&L, and its agents, as Customer's attorney
in fact, to execute and file, without Customer's involvement, any necessary
UCC-1 Financing Statements and continuation statements, acknowledging that the
Equipment listed in Schedule "A" is subject to a lease agreement between B&L and
Customer, in order to protect the lessor interest of B&L in the Equipment.

6. Customer agrees that, for the period of this Agreement set forth above,
Customer shall purchase all of its requirements for single-use disposable blades
for use with the Hansatome (R) Microkeratome from B&L. Customer shall order
Accuglide Blades at the price set forth in Schedule A. Accuglide (R) Blades
shall be ordered by Customer and sold by B&L, and the purchase price therefor,
in accordance with and subject to B&L's then current terms and conditions of
sale.

II. Duties of B&L

1.  B&L agrees to perform initial start-up and installation of the Equipment.

2.  B&L shall provide maintenance and repair service to the Equipment at its
expense during the Term of this Agreement.

III. Release of Obligation/Termination of Program

1. This program may be terminated at any time after six (6) months by either
party upon ninety (90) days prior written notice, given in accordance with IV.8.

2.  Upon termination of the Agreement or the end of the Term, Customer shall
have the following options:

    (i)  Purchase the B&L equipment for the purchase price stated in Schedule A;
         or
    (ii) return the Equipment to B&L ; or
    (iii)continue leasing the Equipment on a month-to-month basis, until
         terminated by either party upon ninety (90) days prior written notice.

3. Customer shall notify B&L no later than ninety (90) days prior to the end of
the Term which option Customer plans to exercise.

4. In the event that Customer shall elect the option to purchase the equipment
pursuant to Schedule A, B&L agrees to credit fifty percent (50%) of all Rentals
paid toward Customer's payment of the Purchase Price. B&L shall promptly notify
Customer by invoice of the balance due on the Purchase Price after applying the
Credit, and Customer shall pay the invoice within thirty (30) days of its
exercise of the option to purchase.

                                        2

<PAGE>
5. In the event that Customer shall fail to notify B&L of its election pursuant
to III.3, the Agreement will continue on a month-to-month basis until terminated
by either party upon ninety (90) days prior written notice.

6. In the event that Customer becomes a "debtor" in any proceeding under the
federal Bankruptcy Act or any state insolvency law, or makes an assignment for
the benefit of creditors, or is adjudicated bankrupt or insolvent, or admits in
writing Customer's inability to pay its debts as they mature, this leases shall
immediately terminate and the Equipment shall be returned to B&L. B&L shall have
all of the rights and remedies of a secured creditor which are permitted or
provided for under the Uniform Commercial Code, without the need of specifically
enumerating them in this Agreement, including, but not necessarily limited to,
the right to seize the Equipment without breach of peace.

IV. General Terms

1. This Agreement is not assignable by Customer to a third party without the
prior written consent of B&L. B&L may assign this Agreement to an affiliate or
successor upon written notice to Customer.

2. Title to the Equipment shall remain with B&L throughout the term of this
Agreement and Customer agrees to execute any documents requested by B&L to
evidence same.

3. This Agreement is not binding upon B&L until accepted and executed on behalf
of B&L at its office in Claremont, California.

4.  This Agreement shall be construed in accordance with and governed by New
York law.

5. This Agreement states the entire agreement of the parties with respect to the
subject matter hereof, and all oral agreements, understandings and
representations have been incorporated.

6. The prevailing party in any litigation brought under this Agreement shall be
entitled to recover, as part of its judgment against the other, its reasonable
attorneys' fees, costs and expenses.

7. Risk of loss to the Equipment is on Customer, and any such loss, damage or
destruction will not have the effect of discharging any obligation of Customer
under this Agreement.

8. Any notice hereunder will be in writing and will be effective when received
at the address set forth above or, if sent by first class mail to such address,
four (4) business days after deposit in the U.S. mails with postage prepaid.
Either party, by notice, may change its address for receiving notices hereunder.

9. It is agreed that the terms, conditions and discounts granted in this
Agreement are to remain confidential. They are not to be revealed to outside
physicians, hospitals, ambulatory surgery centers, groups, vendors, or other
outside resources unless required by law.

                                        3
<PAGE>
10. No failure or delay at any time by B&L to exercise any right hereunder, or
to enforce any particular provision hereof, will be construed or operate as a
waiver of its right to insist upon the strict performance of, or the enforcement
of its rights with respect to, such provisions(s) or any other provisions(s)
hereof at any time.

Agreed to and accepted by authorized representatives of both parties as of the
dates set forth below:

B&L                                      CUSTOMER:
BAUSCH AND LOMB                          Lasik America, Inc.

Signature:                               Signature: /s/ Howard Silverman
           ---------------------------              --------------------------

Print Name: Ron Esola                    Print Name:    Howard Silverman
           ---------------------------               -------------------------

Title: Director, Commercial Operations   Title:         CEO
      --------------------------------         -------------------------------

Date:                                       Date:       5/23/01
      --------------------------------           -----------------------------
Telepnone: 800-521-2020 extension 1454      Telephone:  505-837-2020
          ----------------------------                ------------------------

--------------------------------------------------------------------------------
This Agreement offer valid through:                              May 31, 2001
--------------------------------------------------------------------------------

                                        4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}]]